Vemika Chandra Selected Research

Endotoxins

7/2015

Nuclear Receptor Nr4a2 Promotes Alternative Polarization of Macrophages and Confers Protection in Sepsis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vemika Chandra Research Topics

Disease

4	Tuberculosis (Tuberculoses) 01/2016 - 06/2012
1	Hematologic Diseases (Blood Diseases) 01/2022
1	Bone Marrow Failure Disorders 01/2018
1	Fanconi Anemia (Fanconi's Anemia) 01/2018
1	Leukemia 01/2017
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2017
1	Neoplasms (Cancer) 01/2017
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2017
1	Hematologic Neoplasms (Hematological Malignancy) 01/2017
1	Sepsis (Septicemia) 07/2015
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 05/2015
1	Infections 04/2013

Drug/Important Bio-Agent (IBA)

2	LipidsIBA 01/2016 - 06/2012
2	Interleukin-10 (Interleukin 10)IBA 11/2015 - 04/2013
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 04/2013 - 06/2012
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Janus Kinase InhibitorsIBA 01/2017
1	Ligases (Synthetase)IBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	UbiquitinIBA 01/2017
1	Janus Kinase 2IBA 01/2017
1	LigandsIBA 01/2016
1	Mycolic Acids (Mycolic Acid)IBA 01/2016
1	EndotoxinsIBA 07/2015
1	Member 2 Group A Nuclear Receptor Subfamily 4IBA 07/2015
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 05/2015
1	Calcitriol (Calcijex)FDA LinkGeneric 05/2015
1	Vitamin D FDA LinkGeneric 05/2015
1	EnzymesIBA 01/2015
1	Messenger RNA (mRNA)IBA 06/2012
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 06/2012
1	Member 2 Group C Nuclear Receptor Subfamily 2IBA 06/2012

Therapy/Procedure

1	Hematopoietic Stem Cell Transplantation 01/2022
1	Therapeutics 01/2016